Transcriptional repression of HER2 by ANO1 Cl− channel inhibition in human breast cancer cells with resistance to trastuzumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transcriptional repression of HER2 by ANO1 Cl− channel inhibition in human breast cancer cells with resistance to trastuzumab

Published:2017-01 Issue:1 Volume:482 Page:188-194
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Fujimoto Mayu,Inoue Takahiro,Kito Hiroaki,Niwa Satomi,Suzuki Takayoshi,Muraki Katsuhiko,Ohya Susumu

Funder

KAKENHI

Kyoto Pharmaceutical Univ. and Aichi-Gakuin Univ.

MEXT

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference32 articles.

1. CLC-3 channels in cancer;Hong;Oncol. Rep.,2015

2. The Ca2+-activated Cl− channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis;Qu;Cancer Med.,2014

3. Role of volume-regulated and calcium-activated anion channels in cell volume homeostasis cancer and drug resistance;Hoffmann;Channels Austin,2015

4. Functional role of the Ca2+-activated Cl− channel DOG1/TMEM16A in gastrointestinal stromal tumor cells;Berglund;Exp. Cell Res.,2014

5. Inhibition of Ca2+-activated Cl− channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma;Liu;Cancer Lett.,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TMEM16A ion channel: A novel target for cancer treatment;Life Sciences;2023-10

2. Ion channels and their role in chemo-resistance;Ion Channels in Cancer;2023

3. DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancer;HISTOL HISTOPATHOL;2022

4. Combinatorial Therapy of Cancer: Possible Advantages of Involving Modulators of Ionic Mechanisms;Cancers;2022-05-30

5. Role of ANO1 in tumors and tumor immunity;Journal of Cancer Research and Clinical Oncology;2022-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3